✦ LIBER ✦

A Double-Blind, Randomized, Placebo-Controlled, Two-Dose Comparative Study of Botulinum Toxin Type A for Treating Glabellar Lines in Japanese Subjects

✍ Scribed by Michael A. C. Kane

Publisher: Springer
Year: 2008
Tongue: English
Weight: 91 KB
Volume: 32
Category: Article
ISSN: 0364-216X
DOI: 10.1007/s00266-008-9197-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-Blind, Randomized, Placebo-Cont

A Double-Blind, Randomized, Placebo-Controlled, Two-Dose Comparative Study of Botulinum Toxin Type A for Treating Glabellar Lines in Japanese Subjects

✍ Kiyonori Harii; Makoto Kawashima 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 359 KB

A Double-Blind, Randomized, Placebo-Cont

A Double-Blind, Randomized, Placebo-Controlled, Two-Dose Comparative Study of Botulinum Toxin Type A for Treating Glabellar Lines in Japanese Subjects: What If Sample Size and Statistical Tests Mattered?

✍ Alberto Mangano; Andrea Albertin; Luca La Colla 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 93 KB

Botulinum toxin type A for drooling in P

Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla

Botulinum toxin type-A in the prophylact

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

✍ Giorgio Sandrini; Armando Perrotta; Cristina Tassorelli; Paola Torelli; Filippo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Efficacy and safety of botulinum type A

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study

✍ Daniel Truong; Drake D. Duane; Joseph Jankovic; Carlos Singer; Lauren C. Seeberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia. This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States. Ei